The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $102.53

Today's change+1.59 +1.58%
Updated February 9 4:02 PM EST. Delayed by at least 15 minutes.
 

Laboratory Corporation of America Holdings

NYSE: LH
Last

(U.S.) $102.53

Today's change+1.59 +1.58%
Updated February 9 4:02 PM EST. Delayed by at least 15 minutes.

Laboratory Corporation of America Holdings up sharply

Laboratory Corporation of America Holdings closed up sharply Tuesday, rallying (U.S.)$1.59 or 1.58% to (U.S.)$102.53. Over the last five days, shares have lost 6.22% and sit 4.85% above their 52-week low. This security has performed in-line with the S&P 500 during the last year.

Key company metrics

  • Open(U.S.) $100.06
  • Previous close(U.S.) $100.94
  • High(U.S.) $103.65
  • Low(U.S.) $99.63
  • Bid / Ask(U.S.) $97.49 / (U.S.) $107.76
  • YTD % change-17.07%
  • Volume1,299,094
  • Average volume (10-day)1,055,728
  • Average volume (1-month)992,896
  • Average volume (3-month)1,025,689
  • 52-week range(U.S.) $97.79 to (U.S.) $131.19
  • Beta0.88
  • Trailing P/E22.68×
  • P/E 1 year forward13.00×
  • Forward PEG1.12×
  • Indicated annual dividend--
  • Dividend yield0.00%
  • Trailing EPS(U.S.) $4.52
Updated February 9 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+5.61%

Based on its net profit margin of 5.61%, Laboratory Corporation of America Holdings is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.02%Sector:HealthcareIndustry:Healthcare Facilities
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue2,3172,2691,7931,513
Total other revenue--------
Total revenue2,3172,2691,7931,513
Gross profit763775596547
Total cost of revenue1,5541,4951,197966
Total operating expense2,0101,9481,6631,294
Selling / general / administrative383392415310
Research & development--------
Depreciation / amortization47473115
Interest expense (income), net operating--------
Unusual expense (income)2614192
Other operating expenses, total--------
Operating income307321130219
Interest income (expense), net non-operating-56-58-104-32
Gain (loss) on sale of assets--------
Other--------
Income before tax25026430188
Income after tax1531691120
Income tax, total97962968
Net income1531681120
Total adjustments to net income--------
Net income before extra. items1531681120
Minority interest0000
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1531681120
Inc. avail. to common incl. extra. items1531681120
Diluted net income1531681120
Dilution adjustment00--0
Diluted weighted average shares1031039486
Diluted EPS excluding extraordinary itemsvalue per share1.481.640.011.39
Dividends per sharevalue per share0.000.000.00--
Diluted normalized EPSvalue per share1.641.730.141.40